Altered expression of apoptotic genes in response to OCT4B1 suppression in human tumor cell lines
- 11 July 2014
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (10) , 9999-10009
Abstract
OCT4B1 is a newly discovered spliced variant of OCT4 which is primarily expressed in pluripotent and tumor cells. Based on our previous studies, OCT4B1 is significantly overexpressed in tumors, where it endows an anti-apoptotic property to tumor cells. However, the mechanism by which OCT4B1 regulates the apoptotic pathway is not yet elucidated. Here, we investigated the effects of OCT4B1 suppression on the expression alteration of 84 genes involved in apoptotic pathway. The AGS (gastric adenocarcinoma), 5637 (bladder tumor), and U-87MG (brain tumor) cell lines were transfected with OCT4B1 or irrelevant siRNAs. The expression level of apoptotic genes was then quantified using a human apoptosis panel-PCR kit. Our data revealed an almost similar pattern of alteration in the expression profile of apoptotic genes in all three studied cell lines, following OCT4B1 suppression. In general, the expression of more than 54 apoptotic genes (64 % of arrayed genes) showed significant changes. Among these, some up-regulated (CIDEA, CIDEB, TNFRSF1A, TNFRSF21, TNFRSF11B, TNFRSF10B, and CASP7) and down-regulated (BCL2, BCL2L11, TP73, TP53, BAD, TRAF3, TRAF2, BRAF, BNIP3L, BFAR, and BAX) genes had on average more than tenfold gene expression alteration in all three examined cell lines. With some minor exceptions, suppression of OCT4B1 caused upregulation of pro-apoptotic and down-regulation of anti-apoptotic genes in transfected tumor cells. Uncovering OCT4B1 down-stream targets could further elucidate its part in tumorigenesis, and could lead to finding a new approach to combat cancer, based on targeting OCT4B1.Keywords
This publication has 32 references indexed in Scilit:
- Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significanceMolecular and Cellular Biochemistry, 2013
- Gene Network Revealed Involvements of Birc2, Birc3 and Tnfrsf1a in Anti-Apoptosis of Injured Peripheral NervesPLOS ONE, 2012
- IAPs: Guardians of RIPK1Cell Death & Differentiation, 2011
- Oct4, a novel marker for human gastric cancerJournal of Surgical Oncology, 2009
- BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in CancerCritical Reviews in Clinical Laboratory Sciences, 2006
- Oct4 pseudogenes are transcribed in cancersBiochemical and Biophysical Research Communications, 2005
- TRAF Family Proteins Link PKR with NF-κB ActivationMolecular and Cellular Biology, 2004
- Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP geneOncogene, 2003
- TRAF1 is a TNF inducible regulator of NF‐κB activationFEBS Letters, 1999
- A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryoNature, 1990